Emiliia Bigaeva

Emiliia Bigaeva, MSc is an active medical researcher affiliated with the University of Groningen whose work contributes to UN Sustainable Development Goals related to health and well-being. Her research profile demonstrates significant contributions to medical science with 22 research outputs including articles, patents, and conference presentations.

Her primary research expertise encompasses:

• Ex Vivo Medicine and tissue slice techniques
• Fibrosis mechanisms and fibrogenesis
• Gut mucosa biology and intestinal disease
• RNA sequencing and single-cell gene expression analysis
• Development of treatments for inflammatory bowel diseases

Bigaeva's publication record shows consistent research activity from 2021 through 2025, with particular focus on understanding cellular and molecular mechanisms in gastrointestinal diseases and fibrosis. Her work spans methodological advances in tissue analysis to translational research developing potential treatments for conditions like ulcerative colitis and primary sclerosing cholangitis.

Her scientific contributions include:

• Research on cellular signatures in intestinal graft transplantation
• Studies characterizing inflammatory bowel disease in primary sclerosing cholangitis patients
• Patent development for ulcerative colitis treatments
• Methodological innovations in gut mucosa dissociation protocols
• Advancements in the Scar-in-a-Jar system for anti-fibrotic drug screening

Bigaeva has demonstrated academic service through her role as Member of the scientific committee for PhD Day Groningen 2015. Her research has garnered significant scholarly attention, with multiple publications accumulating dozens of citations and high download counts in institutional repositories, indicating substantial impact in her field.